Two new donor-funded fellowships are being launched this year at UMass Chan to recruit recent postdoctoral scientists and, through intensive mentoring and resource support, foster their development as independent investigators. The fellowships align with the vision embodied in The Morningside Foundation’s transformational $175 million gift in 2021.  

Shan Lu MD, PhD, co-authored a pair of studies related to the Phase I clinical trial of a polyvalent DNA/prime-protein boost vaccine to prevent HIV, marking the latest step in a decades long quest to harness the power of DNA vaccines to address a major global health need.  

Andrés Colubri, MFA, PhD, and his lab have partnered with a team at Massachusetts General Hospital on a mobile app that enables infectious disease research and can keep international travelers healthy.

Recently published analyses from the Women’s Health Initiative found that hormone therapy reduces bothersome symptoms of menopause among women under 60 or in early menopause, but it does not prevent cardiovascular disease or other chronic diseases. Nursing professor Sybil Crawford discusses what research suggests about staying healthy throughout a woman’s middle and later years.  

UMass Chan Medical School and Worcester’s health care organizations are embarking on a collaborative electronic health data-sharing initiative to understand health inequities, trends, risk factors and outcomes surrounding opioid use disorders.  

Postdoctoral fellow Samara Vilca, PhD, has been awarded the second phase of the National Institutes of Health Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award.